Never miss a story

Get subscribed to our newsletter


×
Teenagers prefer Snapchat over Facebook, Instagram: Study. Pixabay

Hitting out at Facebook once again, Snap CEO Evan Spiegel has suggested the social networking giant to not only copy itss features but also its data protection policies.

During a ReCode conference in California on Tuesday, the Snapchat chief said Facebook has failed to sufficiently overhaul its user privacy protections.


“We would really appreciate it if they copied our data protection practices also,” Spiegel was quoted as saying during the event.

“Fundamentally, I think the changes have to go beyond window dressing to real changes to the ways that these platforms work,” he added.

Reacting to Spiegel, Facebook Chief Security Officer Alex Stamos tweeted on Wednesday, “Snapchat’s implicit promise that photos really disappear combined with poor API security has lead to serious mass leaks of revenge porn. So no, I don’t think copying Snapchat would be a smart move.”


Facebook CEO of Mark Zuckerberg (Wikimedia commons)

The photo-sharing platform Snapchat today has 191 million users globally, including nearly 9 million in India.

Facebook has reportedly copied several Snapchat features, including the most notable one called “Stories”.

Snapchat on April Fools’ Day had trolled Facebook by introducing a filter that makes it appear as if a Russian bot has liked your post.

The filter targeted Facebook following reports that said more than 50,000 bots on Facebook, with links to the Russian government, were used to influence the 2016 US Presidential election.

Also Read: Snapchat Partners With Tyroo To Drive Ad-Monetisation In India

While redesigning Snapchat in 2017, Spiegel took a dig at Facebook.

“The company is redesigning its app to separate media and social communications, making it easier to use and understand,” he said.

“We think this helps to guard against fake news and mindless scrambles for friends or unworthy distractions,” Spiegel said, taking a dig at Facebook and Twitter.

The design overhaul, however, didn’t go well with the Snapchat users and the company has reinstated most of the old design features. (IANS)


Popular

Photo by Alexander Shatov on Unsplash

Twitter has confirmed that its algorithms amplify right-leaning political content.

By Nikhila Natarajan

In a continuing study on the effects of machine learning (ML) on public conversation, Twitter has confirmed that its algorithms amplify right-leaning political content. "In six out of seven countries - all but Germany - tweets posted by accounts from the political right receive more algorithmic amplification than the political left when studied as a group," Twitter blogged.

"Right-leaning news outlets, as defined by the independent organisations, see greater algorithmic amplification on Twitter compared to left-leaning news outlets." Since 2016, Twitter users are able to choose between viewing algorithmically ordered tweets first in their home timeline or viewing the most recent tweets in reverse chronological order.

"An algorithmic home timeline displays a stream of tweets from accounts we have chosen to follow on Twitter, as well as recommendations of other content Twitter thinks we might be interested in based on accounts we interact with frequently, tweets we engage with, and more. "As a result, what we see on our timeline is a function of how we interact with Twitter's algorithmic system, as well as how the system is designed."

The new research is based on tweets of elected officials of House of Commons members in Canada, the French National Assembly, the German Bundestag, House of Representatives in Japan, Congress of Deputies of Spain, House of Commons in the UK, and official and personal accounts of House of Representatives and Senate members in the US, as well as news outlets, from April 1 to August 15, 2020.

gold Apple iPhone 6s displaying Twitter logo Tweets about political content from elected officials, regardless of party or whether the party is in power, do see algorithmic amplification when compared to political content on the reverse chronological timeline. | Photo by Sara Kurfeß on Unsplash

Keep Reading Show less
Flickr

Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal.

Even as India celebrates reaching a milestone of 100 crore Covid vaccine doses, Snapdeal co-founder and COO Rohit Bansal on Friday lauded a man who facilitated 64 registrations for the vaccine on the CoWin portal. In a video shared on his Facebook and Twitter page, Bansal hailed Sonu Kumar as a "citizen celebrity".

Bansal said that Kumar not only helped "just co-workers and family but complete strangers too. With patience, empathy and uncanny jugaad". He added that Kumar joined him "many moons ago" and completed his open school from a parking lot.

"Education has helped this wonderful man enable others to get India back on track. Bravo! The CoWin portal on Thursday mentioned that a total of 100 crore vaccine doses has been administered so far to the eligible population under the vaccination drive in India, nine months after the nationwide inoculation programme was started to protect the people against Covid-19.

"It's a cause of significant celebration and happiness," Bansal said in the video. He said that while people just help a few around them, Kumar "bridged the digital gap" for 64 people, who were finding it difficult to register themselves online on the vaccine portal. Kumar said he doesn't feel that he has contributed much towards the 100 crore vaccine dose count. "I have been able to help only 64 people, if I was able to help more I would have been happier." (IANS/ MBI)


Keep Reading Show less
VOA

A health worker counts antiretroviral drug tablets for a patient at The AIDS Support Organization (TASO) in the capital Kampala, Uganda, July 12, 2012.

KAMPALA, UGANDA — Uganda has kickstarted a trial for the injectable HIV drugs cabotegravir and rilpivirine. Researchers and those living with HIV say the trial will likely end pill fatigue, fight stigma, improve adherence and ensure patients get the right dosage.

The two drugs have been in use as tablets. The World Health Organization last year licensed their use as injectables.

Keep reading... Show less